PRLAX | SLARX | PRLAX / SLARX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 31 years | 10 years | - |
Gain YTD | 3.574 | 2.634 | 136% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 307M | 226M | 136% |
Annual Yield % from dividends | 2.51 | 3.53 | 71% |
Returns for 1 year | -18.92 | -21.78 | 87% |
Returns for 3 years | 5.07 | 4.60 | 110% |
Returns for 5 years | -23.94 | -13.40 | 179% |
Returns for 10 years | -6.01 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JACFX | 19.27 | 0.17 | +0.89% |
JHancock Mid Cap Growth NAV | |||
PGUAX | 14.41 | 0.08 | +0.56% |
Virtus Duff & Phelps Global Infras A | |||
HLEZX | 16.61 | 0.08 | +0.48% |
Harding Loevner Instl Emerg Mkts Z | |||
VSNGX | 65.66 | 0.21 | +0.32% |
JPMorgan Mid Cap Equity I | |||
MSDMX | 12.36 | 0.02 | +0.16% |
Morgan Stanley Emerging Mkt ex China R6 |